The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...

Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...

The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...

The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...

A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...